Pathkey.ai Ltd
Research Pathkey.ai Ltd (PKY) on Bullrun: market cap AUD 27.03M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPKY
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyAUD
- Market capAUD 27.03M
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 27.03M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.01 | n/a | n/a | n/a |
| FY2024 | AUD 397.64K | -AUD 3.13M | -AUD 2.07M | 100.0% | -0.02 | AUD 374.65K | n/a | -AUD 90.16K |
| FY2023 | AUD 613.61K | -AUD 1.73M | -AUD 1.37M | 100.0% | -0.02 | AUD 452.88K | AUD 300.00K | -AUD 403.59K |
| FY2022 | AUD 880.76K | -AUD 2.09M | -AUD 1.53M | 100.0% | -0.03 | AUD 786.33K | n/a | AUD 267.01K |
| FY2021 | AUD 755.97K | -AUD 1.14M | -AUD 918.13K | 100.0% | n/a | AUD 2.32M | n/a | AUD 2.19M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-13 | AUD 27.03M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Pathkey.ai Ltd
Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Pathkey.ai Ltd's market cap?
Pathkey.ai Ltd's market capitalization is AUD 27.03M.
What does Pathkey.ai Ltd do?
Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.